<VariationArchive VariationID="1441113" VariationName="NM_001673.5(ASNS):c.540del (p.Leu181fs)" VariationType="Deletion" Accession="VCV001441113" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1362260" VariationID="1441113">
      <GeneList>
        <Gene Symbol="ASNS" FullName="asparagine synthetase (glutamine-hydrolyzing)" GeneID="440" HGNC_ID="HGNC:753" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97851677" stop="97928441" display_start="97851677" display_stop="97928441" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="97481428" stop="97501853" display_start="97481428" display_stop="97501853" Strand="-" />
          </Location>
          <OMIM>108370</OMIM>
        </Gene>
        <Gene Symbol="CZ1P-ASNS" FullName="CZ1P-ASNS readthrough" GeneID="107986827" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97852117" stop="97972358" display_start="97852117" display_stop="97972358" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001673.5(ASNS):c.540del (p.Leu181fs)</Name>
      <CanonicalSPDI>NC_000007.14:97859345:AAAA:AAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="97859346" stop="97859346" display_start="97859346" display_stop="97859346" variantLength="1" positionVCF="97859345" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="97488658" stop="97488658" display_start="97488658" display_stop="97488658" variantLength="1" positionVCF="97488657" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>L160fs</ProteinChange>
      <ProteinChange>L181fs</ProteinChange>
      <ProteinChange>L98fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147989.1" sequenceAccession="NR_147989" sequenceVersion="1" change="n.2169del">
            <Expression>NR_147989.1:n.2169del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178075.2" sequenceAccession="NM_001178075" sequenceVersion="2" change="c.477del">
            <Expression>NM_001178075.2:c.477del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171546.1" sequenceAccession="NP_001171546" sequenceVersion="1" change="p.Leu160fs">
            <Expression>NP_001171546.1:p.Leu160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352496.2" sequenceAccession="NM_001352496" sequenceVersion="2" change="c.540del">
            <Expression>NM_001352496.2:c.540del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001339425.1" sequenceAccession="NP_001339425" sequenceVersion="1" change="p.Leu181fs">
            <Expression>NP_001339425.1:p.Leu181fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001673.5" sequenceAccession="NM_001673" sequenceVersion="5" change="c.540del" MANESelect="true">
            <Expression>NM_001673.5:c.540del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001664.3" sequenceAccession="NP_001664" sequenceVersion="3" change="p.Leu181fs">
            <Expression>NP_001664.3:p.Leu181fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.97488661del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.97488661del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.97859349del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.97859349del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033870.2" sequenceAccession="NG_033870" sequenceVersion="2" change="g.74217del">
            <Expression>NG_033870.2:g.74217del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178076.2" sequenceAccession="NM_001178076" sequenceVersion="2" change="c.291del">
            <Expression>NM_001178076.2:c.291del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171547.1" sequenceAccession="NP_001171547" sequenceVersion="1" change="p.Leu98fs">
            <Expression>NP_001171547.1:p.Leu98fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178077.1" sequenceAccession="NM_001178077" sequenceVersion="1" change="c.291del">
            <Expression>NM_001178077.1:c.291del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171548.1" sequenceAccession="NP_001171548" sequenceVersion="1" change="p.Leu98fs">
            <Expression>NP_001171548.1:p.Leu98fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133436.3" sequenceAccession="NM_133436" sequenceVersion="3" change="c.540del">
            <Expression>NM_133436.3:c.540del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_597680.2" sequenceAccession="NP_597680" sequenceVersion="2" change="p.Leu181fs">
            <Expression>NP_597680.2:p.Leu181fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_183356.4" sequenceAccession="NM_183356" sequenceVersion="4" change="c.540del">
            <Expression>NM_183356.4:c.540del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_899199.2" sequenceAccession="NP_899199" sequenceVersion="2" change="p.Leu181fs">
            <Expression>NP_899199.2:p.Leu181fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133436.3" sequenceAccession="NM_133436" sequenceVersion="3" change="c.540delT">
            <Expression>NM_133436.3:c.540delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="866033169" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001673.5(ASNS):c.540del (p.Leu181fs) AND not provided" Accession="RCV001950561" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001673.5(ASNS):c.540del (p.Leu181fs) AND Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" Accession="RCV002307802" Version="1">
        <ClassifiedConditionList TraitSetID="12477">
          <ClassifiedCondition DB="MedGen" ID="C3809971">Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-19" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27422383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30057589</ID>
        </Citation>
        <DescriptionHistory Dated="2022-11-18">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="12477" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18463" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome</ElementValue>
                <XRef ID="MONDO:0014258" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASNS DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="615574" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Asparagine synthetase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ASNSD</ElementValue>
                <XRef Type="MIM" ID="615574" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17617" />
                <XRef ID="17617" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Asparagine synthetase deficiency (ASD) mainly presents as a triad of congenital microcephaly, severe developmental delay, and axial hypotonia followed by spastic quadriplegia. Low cerebrospinal fluid (CSF) asparagine level can help the clinician in differentiating this disorder from others. In most cases age of onset of apnea, excessive irritability, and seizures is soon after birth. Affected individuals typically do not acquire any developmental milestones. Spastic quadriplegia can lead to severe contractures of the limbs and neurogenic scoliosis. Feeding difficulties (gastroesophageal reflux disease, frequent vomiting, swallowing dysfunction, and gastroesophageal incoordination) are a significant problem in most affected individuals. A majority have cortical blindness. MRI findings are nonspecific but may include generalized atrophy and simplified gyral pattern.</Attribute>
                <XRef ID="NBK525916" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30234940</ID>
                <ID Source="BookShelf">NBK525916</ID>
              </Citation>
              <XRef ID="391376" DB="Orphanet" />
              <XRef ID="C3809971" DB="MedGen" />
              <XRef ID="MONDO:0014258" DB="MONDO" />
              <XRef Type="MIM" ID="615574" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5082139" SubmissionDate="2022-11-10" DateLastUpdated="2022-11-19" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="NM_133436.3:c.540delT|MedGen:C3809971" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002600592" DateUpdated="2022-11-19" DateCreated="2022-11-19" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: ASNS c.540delT (p.Leu181PhefsX10) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. A truncation downstream of this position has been classified as likely pathogenic by our laboratory, and others are classified as pathogenic in ClinVar. The variant allele was found at a frequency of 4e-06 in 250990 control chromosomes. To our knowledge, no occurrence of c.540delT in individuals affected with Asparagine Synthetase Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, classifying the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133436.3:c.540delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C3809971" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12274151</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4244077" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="8034570|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002225847" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27422383</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30057589</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with ASNS-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu181Phefs*10) in the ASNS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASNS are known to be pathogenic (PMID: 27422383, 30057589).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.97488658del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5082139" TraitType="Disease" MappingType="Name" MappingValue="Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" MappingRef="Preferred">
        <MedGen CUI="C3809971" Name="Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4244077" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

